Navigation Links
Mr. Richard Decker Appointed Technical Director of Edgewood Chemical Biological Center
Date:2/27/2008

ABERDEEN PROVING GROUND, Md., Feb. 27 /PRNewswire/ -. Mr. Richard W. Decker II will be officially appointed as Technical Director of the Edgewood Chemical Biological Center (ECBC) March 2. He has served as acting director since February after serving as Director of Engineering within the organization since February 2005.

As Technical Director, Mr. Decker is responsible for 1,600 Department of the Army civilians, soldiers and on-site contractors located at Aberdeen Proving Ground, MD; Pine Bluff Arsenal, AR; and Rock Island, Ill. Those employees conduct research, engineering and field operations in support of the Department of Defense and other government agencies, by providing innovative science, technology, and engineering solutions for chemical and biological defense.

Between June 2002 and February 2005, Mr. Decker served as the Deputy Joint Program Executive Officer for Chemical Biological Defense, at Fort Belvoir, Va. Between September 2001 and June 2002, he served as the Deputy Director for Engineering at ECBC. Earlier in his career, he served as a Systems Manager for several protective mask programs and as the Program Manager for Smoke/Obscurants at Aberdeen Proving Ground.

Mr. Decker holds two Bachelor of Science degrees: one in Mechanical Engineering from the University of Maryland and the other in Chemistry from the University of Maryland, Baltimore County. A longtime resident of Harford Country, Maryland, he resides in Kingsville. Mr. Decker is married to Dr. Su Willard, with two children, Dr. Brooke Decker (27) and Jon Decker (24).

ECBC is the Army's principal research and development center for chemical and biological defense technology, engineering and field operations. ECBC has achieved major technological advances for the warfighter and for our national defense, with a long and distinguished history of providing the Armed Forces with quality systems and outstanding customer service. ECBC is a US Army Research, Development and Engineering Command laboratory located at the Edgewood Area of Aberdeen Proving Ground, Maryland. For more information about the Edgewood Chemical Biological Center, please visit our Web site at http://www.ecbc.army.mil or call (410) 436-3610.


'/>"/>
SOURCE Edgewood Chemical Biological Center
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year
2. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
3. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
4. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
5. Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer
6. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
7. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
8. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
9. John Marshall and Kevin McGuinness Appointed to Ellex Board
10. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
11. David Mott Appointed Non Executive Director at Shire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
Breaking Biology Technology:
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
(Date:3/22/2016)... , March 22, 2016 ... report "Electronic Sensors Market for Consumer Industry by Type ... Others), Application (Communication & IT, Entertainment, Home ... Global Forecast to 2022", published by MarketsandMarkets, ... expected to reach USD 26.76 Billion by ...
(Date:3/21/2016)... -- Unique technology combines v ...   Xura, Inc. (NASDAQ: ... communications services, today announced it is working alongside SpeechPro ... particularly those in the Financial Services Sector, the ability ... a mobile app, alongside, and in combination with, traditional ...
Breaking Biology News(10 mins):